Why are people complaining?
Peter J. Pits
Gilead Sciences just announced it will charge $3,120 for a full course of Remdesivir, the first new FDA-approved treatment for COVID-19. Some kneejerk members of Congress like Lloyd Doggett (D-Texas) immediately condemned that price tag as "outrageous.
Wednesday, September 16, 2020